所有图片(3)
About This Item
经验公式（希尔记法）:
C25H30ClN3
CAS号:
分子量:
407.98
Beilstein:
3580948
MDL號碼:
分類程式碼代碼:
12171500
PubChem物質ID:
NACRES:
NA.47
推荐产品
形狀
solution
儲存期限
Expiry date on the label
IVD
for in vitro diagnostic use
濃度
2.3%
pH值
4.6
應用
hematology
histology
儲存溫度
room temp
SMILES 字串
[Cl-].CN(C)c1ccc(cc1)\C(c2ccc(cc2)N(C)C)=C3/C=C\C(C=C3)=[N+](/C)C
InChI
1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1
InChI 密鑰
ZXJXZNDDNMQXFV-UHFFFAOYSA-M
正在寻找类似产品? 访问 产品对比指南
應用
用于革兰氏染色方案HT90(Gram Stain Procedure No. HT90)。
成分
含有2.3%认证的结晶紫、0.1%草酸铵和20%乙醇(SD3A变性酒精)。
訊號詞
Warning
危險分類
Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 3
儲存類別代碼
3 - Flammable liquids
水污染物質分類（WGK）
WGK 2
閃點（°F）
100.0 °F - closed cup
閃點（°C）
37.8 °C - closed cup
個人防護裝備
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
其他客户在看
Bin Xiao et al.
Cell reports, 31(4), 107571-107571 (2020-04-30)
Mechanistic target of rapamycin complex 1 (mTORC1) is a master modulator of cellular growth, and its aberrant regulation is recurrently documented within breast cancer. While the small GTPase Rheb1 is the canonical activator of mTORC1, Rheb1-independent mechanisms of mTORC1 activation
Chia-Hsun Fang et al.
Journal of biomedical science, 27(1), 42-42 (2020-03-15)
The underlying mechanism involved in ovarian cancer stemness and chemoresistance remains largely unknown. Here, we explored whether the regulation of c-Kit and plasma membrane prohibitin (PHB) affects ovarian cancer stemness and chemotherapy resistance. Mass spectrum analysis and an in vitro
Chao Wan et al.
Science advances, 6(13), eaay9789-eaay9789 (2020-04-02)
Radiotherapy (RT) is routinely used in cancer treatment, but expansion of its clinical indications remains challenging. The mechanism underlying the radiation-induced bystander effect (RIBE) is not understood and not therapeutically exploited. We suggest that the RIBE is predominantly mediated by
Niklas Gremke et al.
Nature communications, 11(1), 4684-4684 (2020-09-19)
Cancer cells have a characteristic metabolism, mostly caused by alterations in signal transduction networks rather than mutations in metabolic enzymes. For metabolic drugs to be cancer-selective, signaling alterations need to be identified that confer a druggable vulnerability. Here, we demonstrate
Danuta Martuszewska et al.
PloS one, 4(2), e4350-e4350 (2009-02-06)
The Tensin family of intracellular proteins (Tensin1, -2, -3 and -4) are thought to act as links between the extracellular matrix and the cytoskeleton, and thereby mediate signaling for cell shape and motility. Dysregulation of Tensin expression has previously been
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门